Clinical and Radiological Outcomes of Medacta Shoulder System FR

Recruiting now

Conditions studied: Primary Osteoarthritis, Secondary Osteoarthritis, Rotator Cuff Tear Arthropathy, Rheumatoid Arthritis Shoulder, Avascular Necrosis, Fracture, Revision of Shoulder Arthroplasty

In brief

This is a post-marketing surveillance on Medacta Shoulder System

Key facts

Study ID

NCT05926622

Run by

Medacta International SA

People needed

200

Starts

2022-03-15

Expected to finish

2037-03-01

Last updated by the study team

2025-09-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients older than 18 years
• Patient with one of the following diagnosis:
• Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty

You may not qualify if…

• Patients with malignant diseases (at the time of surgery)
• Patients with proven or suspect infections (at the time of surgery)
• Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
• Patients with known incompatibility or allergy to products materials (at the time of surgery)

Where it is running

• Clinique Générale Annecy — Annecy, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.